logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    argenx | Sustainability & Chart

    NL0010832176

    Basic information on argenx

    Location: Netherlands

    Industry: Health Services

    Website

    knob-globe
    66%

    Impact Score

    Description argenx

    argenx is a global immunology company developing antibody-based therapies for the treatment of severe autoimmune diseases and cancer.

    argenx Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare argenx with ...

    argenx

    ?

    Impact Score

    knob-globe
    66%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO Pay Ratio
    CEO nameTim Van Hauwermeiren2025entire-argenx-ar25.pdf12
    CEO-to-median-salary-ratio25Ratio2025entire-argenx-ar25.pdf305
    Employee Turnover Rate
    Employee turnover6%2025entire-argenx-ar25.pdf307
    Gender Pay Gap
    Unadjusted gender pay gap4,6%2025entire-argenx-ar25.pdf305
    Glass Ceiling
    Women in workforce1 134employees2025entire-argenx-ar25.pdf307
    Number of employees1 863people2025entire-argenx-ar25.pdf192
    Women in management50%2025entire-argenx-ar25.pdf304
    Greenhouse Gas Emissions
    Scope 1 emissions2 120tCO2e2025entire-argenx-ar25.pdf291
    Number of employees1 863people2025entire-argenx-ar25.pdf192
    Scope 2 emissions, location based668tCO2e2025entire-argenx-ar25.pdf291
    Harassment and Discrimination at the Workplace
    Incident notification mechanismYes2025entire-argenx-ar25.pdf319
    Retaliation safeguardsYes2025entire-argenx-ar25.pdf302
    Anti-discrimination policyYes2025GD9_Code_of_conduct.pdf4
    Confidentiality mechanismsYes2025entire-argenx-ar25.pdf318
    Renewable Energy
    Total renewable energy consumption0%2025entire-argenx-ar25.pdf290
    Supply Chain
    Scope 3 emissions468 212tCO2e2025entire-argenx-ar25.pdf291
    Scope 2 emissions, location based668tCO2e2025entire-argenx-ar25.pdf291
    Number of employees1 863people2025entire-argenx-ar25.pdf192
    Scope 1 emissions2 120tCO2e2025entire-argenx-ar25.pdf291
    Recycling and Recovery of Waste
    Waste recycled14,78tons2024entire-argenx-ar24.pdf337
    Total waste generation38,6tons2024entire-argenx-ar24.pdf337
    Women on Board
    Women on supervisory board3people2025entire-argenx-ar25.pdf103
    Supervisory board size9people2025entire-argenx-ar25.pdf103
    Women in Management
    Women in management50%2025entire-argenx-ar25.pdf304
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev